Consequently, further study of a large COAD cohort is warranted to verify the prognostic value of NAT1 methylation, and in vivo and in vitro experiments are needed in order to elucidate the biological function of NAT1 and its CpG sites with respect to COAD. This evidence concerns the gene NAT1 and colon adenocarcinoma.